1986 index

1986 INDEX A

Abdomen mass in neuroblastoma, in children, Mar. 187 wall Fixation in rectal prolapse, June 417 reconstruction, flaps for, muscle and myocutaneous, May 366-367 reconstruction, flaps for, muscle and myocutaneous, results, May 381 reconstruction, flaps for, muscle and myocutaneous, use frequency, May 366 reconstruction, omental transposition in, Nov. 829-830 stomach separation from, after gastrostomy, Sept. 689 Abscess of lung, Jan. 38-73 acute, Jan. 61 aerobic infection, Jan. 60-62 amebic, Jan. 76 anaerobic pathogenesis, Jan. 42-49 pathology, Jan. 42-49 anaerobic infection in, Jan. 58-60 in antibiotic era, Jan. 41 aspiration direct percutaneous needle, Jan. 65-67 from oropharynx, Jan. 41-42 transtracheal, Jan. 65-66 carcinoma confused with, Jan. 59 chronic, bronchography of, Jan. 48 classification, Jan. 39 clinical manifestations, Jan. 53-67 CT in, Jan. 64 definition, Jan. 39 diagnosis, Jan. 53-73 drainage, Jan. 70-73 contraindications, Jan. 72-73 external, Jan. 70-72 indications, Jan. 72-73 internal, Jan. 70 dysphagia in (see Dysphagia) hemoptysis and toxicity in. Jan. 63 historical background,“Jan~ 39-41 Klebsiella causing, Jan. 52 lung resection in, Jan. 72-73 928

management, Jan. 67-73 approach to, Jan. 68 Mycobacterium tuberculosis in, Jan. 56 pneumonia (see Pneumonia, in lung abscess) in preantibiotic era, Jan. 39-41 secondary, Jan. 53 specimen handling of, Jan. 66-67 syringe method for, Jan. 66 transport media, Jan. 66-67 sputum in, expectorated, Jan. 65 Staphylococcus aureus in, Jan. 58 Abscess: plantar, in diabetic, Oct. 745, 777-781 Absorption: omentum, Nov. 807 Adenocarcinoma of cervix, clear cell, in children, Mar. 234 of rectum, Dec. 895 of vagina, clear cell, in children, Mar. 234 Adenomatoid anomaly of lung, congenital cystic, Apr. 289-297 classification, Apr. 293 Adhesion: omentum, Nov. 805-807 Aerobic infection: in lung abscess, Jan. 60-62 Age bronchiectasis surgery and, Feb. 133-134 at diagnosis in malignant teratoma, in children, Mar. 218 neuroblastoma and, in children, Mar. 196 pelvic exenteration and, Dec. 882-883 Agenesis lung, Apr. 274-277 unilateral, Apr. 276 pulmonary artery, Apr. 303 trachea, Apr. 256-257 AIDS: isolators for. Julv 540 Air clean-air (see Clean-air) ultraclean (see Ultraclean air) Airflow (see Laminar airflow) Alveolar elements: in embryology of lower respiratory tract, Apr. 252-255 Ambulance: transport isolator for patients, July 513

Amebiasis: pleuropulmonary, Jan. 73-80 Amebic empyema (see Empyema, amebic) lung abscess, Jan. 76 pericarditis with amebic empyema, Jan. 79 Amputation in diabetic above-knee, Oct. 773 ankle pressures and, Oct. 761-762 below-knee, Oct. 773 vascular laboratory criteria for primary healing of, Oct. 764 Chopart healed, Oct. 771 prosthesis, Oct. 772 forefoot, Oct. 746 major, prediction of healing, Oct. 763-764 minor, prediction of healing, Oct. 761-765 prosthesis, in place, Oct. 773 Syme, Oct. 772 toe pressures and, Oct. 762-763 transmetatarsal healed, Oct. 770 orthosis for, Oct. 770 prediction of healing, Oct. 761-765 Anaerobic (see Abscess of lung, anaerobic) Anal orifice encirclement in rectal prolapse, June 432-434 postanal repair after rectal prolapse surgery, June 444-445 sphincters in rectal prolapse, June 405 Anastomosis distal, to vessels in lower third of leg, in diabetic foot, Oct. 758 esophageal, omental transposition in, Nov. 848 gastrointestinal, omental transposition for, Nov. 831 ureteroileal open, Dec. 911 Anemia aplastic, marrow transplant in, July 536-538 in neuroblastoma, in children, Mar. 187 Anesthesia: for open drainage of empyema, Jan. 22-23 Angiodilatation: in diabetic foot, Oct. 748-750 Angiogenesis: omentum, Nov. 805 Ankle joint

Charcot, Oct. 731 in osteomyelitis, muscle flap closure,.May 357 neuropathic, in diabetes, Oct. 732 pressures to predict healing in transmetatarsal and minor amputations in diabetic, Oct. 761-762 Anomalies bronchial, Apr. 257-268 arising from foregut derivatives, Apr. 266-268 bronchopulmonary, congenital, Apr. 251-314 congenital, and Wilms tumor, Mar. 198-199 of lung, congenital cystic adenomatoid, Apr. 289-297 classification, Apr. 293 pulmonary arteriovenous, Apr. 301 pulmonary vascular, Apr. 298-303 in rhabdomyosarcoma, in children, Mar. 171 sequestration, unusual, Apr. 271 Aplasia: lung, Apr. 274-277 Arm (See also Extremities, upper) omental transposition to, Nov. 853 Arteries celiac, Nov. 798 gastroepiploic (see Gastroepiploic artery) iliac, stenosis, in diabetic, angiodilatation, Oct. 749 pedal, anatomy, Oct. 756 peroneal, in in situ bypass in diabetic foot, Oct. 757 pulmonary, agenesis, Apr. 303 reconstruction (see Foot, diabetic, arterial reconstruction in) supply of omentum, Nov. 800 tibial, posterior, systolic pressure measurement in, Oct. 737 Arteriography: in diabetic foot, Oct. 747-748 Arteriovenous fistula: pulmonary, Apr. 299-301 Asphyxiating thoracic dystrophy, Apr. 282 Aspiration in abscess of lung (see Abscess of lung, aspiration) pneumonia (see Pneumonia, aspiration) Asthma: and bronchiectasis, Feb. 149 Ataxia: cerebellar, in neuroblastoma, in children, Mar. 186 Atresia bronchial, Apr. 259-261 929

Atresia (cont.) esophageal, gastrostomy in, Sept. 686-687 tracheal, Apr. 256-257 Attitude: and pelvic exenteration, Dec. 883 Axilla: omental transposition to, Nov. 849-850 B Back

reconstruction, muscle and myocutaneous flaps for, May 367 results, May 381-382 use frequency, May 367 Bacteria -controlled nursing unit, July 519-521 gram-negative, in pneumonia, Jan. 51 Barrier (see Partial barrier) BCNU, July 519-521 Beck-Jianu gastrostomy, Sept. 675 Biceps femoris myocutaneous flap, May 338 Biopsy: in tongue cancer, Aug. 578-579 Bladder: rhabdomyosarcoma, in children. Mar. 174-177 Blood ’ flow detector, Doppler, Oct. 735 supply to omentum, Nov. 798-800 to skin, and flaps, May 330 “Blue toe svndrome,” Oct. 751 Bone flaps that carry, May 351 marrow (see Marrow) vascularized, compound myocutaneous flap carrying, May 352 Bowel, small perforation, in gastrostomy, Sept. 704 prolapse, omental transposition in, Nov. 838 Brachial plexopathy: radiationinduced,omental transposition in. Nov. 850-851 Breast cancer, recurrence, Nov. 819, 820 CT of, Nov. 821 after omental transposition, Nov. 856 metastases, dermal lymphatic, Nov. 825 reconstruction 930

flaps for, muscle and myocutaneous, May 365-366 flaps for, muscle and myocutaneous, results, May 380-381 flaps for, rectus abdominis, May 337 flaps for, use frequency, May 365 omental transposition in, Nov. 828-829 Bronchi aberrant, Apr. 259-260 anatomy of, Feb. 104-111 anomalies, Apr. 257-268 anomalous, arising from foregut derivatives, Apr. 266-268 apicoposterior bronchus, left, Feb. 110 atresia, Apr. 259-261 elements in lower respiratory tract embryology, Apr. 252-255 esophagobronchial fistula, Feb. 144 tracheal, Apr. 258-259 Bronchiectasis, Feb. 97-159 asthma and, Feb. 149 bilateral, total, Feb. 122-123 bronchitis and, Feb. 149 complications, Feb. 145 congenital, Apr. 261 controversial areas concerning, Feb. 145-150 distribution, Feb. 128-129, 135 with empyema, Jan. 28 extent shown bronchographically, Feb. 134-137 fate of chronically shrunken, airless lobe, Feb. 149-150 historical background, Feb. 98-104 of left lung, congenital, Apr. 262 lung resection, anatomical limits of, Feb. 131-133 of middle lobe, Feb. 136-137, 138 natural history, Feb. 129-131 pathology, Feb. 117-129 preservation of apical segment of lower lobe in, Feb. 147-148 resections in, Feb. 139 bilateral, Feb. 140 bilateral, controversy concerning, Feb. 145-146 with cardiovascular surgery, Feb. 141 cause of bronchiectasis, established, Feb. 143-144 complications, Feb. 144-145 “sump,” Feb. 146-147 right, total, Feb. 124 surgery

age and, Feb. 133-134 incidence, Feb. 103 mortality in, Feb. 141 patient selection, Feb. 133-137 planning, value of bronchography in, Feb. 118 pulmonary vascular bed state and, Feb. 137 results, Feb. 138-145 symptomless, as complication, Feb. 148-149 symptoms, Feb. 134 Bronchitis: and bronchiectasis, Feb. 149 Bronchobiliary fistula, Apr. 268 Bronchoesophageal fistula, Jan. 55, Feb. 144 Bronchogenic cyst, Apr. 287-289, 290-291 histologic appearance, Apr. 287 mediastinal, Apr. 266 Bronchography, Feb. 111-117 contrast media for, Feb. 111-113 of empyema, Jan. 29 extent of bronchiectasis shown by, Feb. 134-137 of left upper bronchus, Feb. 108, 109 of lung abscess, chronic, Jan. 48 normal, Feb. 105 in pneumonia aspiration, Jan. 40 chronic destructive, Jan. 47 repeated over 5 year period, Feb. 119 technique, Feb. 113-117 value in planning surgery, Feb. 118 Broncholith: with bronchiectasis, Feb. 144 Bronchopleural fistula, Jan. 36-38 closure of fistula, Jan. 36-38 direct, Jan. 36 after lung resection, Jan. 36-38 muscle flap in, Jan. 36-38 obliteration of space, Jan. 36-38 omental transposition in, Nov. 849 thoracoplasty in, Jan. 38 Bronchopulmonary anomalies: congenital, Apr. 251-314 Bronchus (see Bronchi) Burn patients attempts to reduce endogenous microflora of, July 526-527 isolators for, July 521-526 Button: gastrostomy, Sept. 696, 697 Bypass, in situ vein, in diabetic foot, oct.753-754 new horizons, Oct. 754

C Cancer breast (see Breast, cancer) in children (see Children. cancer) colorectal, morbidity and survivsl after pelvic exenteration, Dec. 899 gastric, omentectomy in, Nov. 812 liver (see Liver cancer) oral (see Oral, cancer) oropharyngeal, smoking and, Aug. 569 ovaries (see Ovaries, cancer) pelvis (see Pelvis, cancer) tongue (see Tongue cancer) Capillaries: in greater omentum (in rabbit), Nov. 796 Carcinoma cervix (see Cervix, carcinoma) confused with lung abscess, Jan. 59 rectum (see Rectum, carcinoma) tongue, verrucuous, Aug. 638-639 Cardiovascular surgery: with pulmonary resection, Feb. 141 Carotid cover-y: omental transposition for, Nov. 843-844 Catheter (see Gastrostomy, catheter) Celiac artery, Nov. 798 Cells germ cell tumors, in children, Mar. 220-221 extragonadal, Mar. 233 granular cell myoblastoma of tongue, Aug. 639 mast, of omentum, Nov. 804-805 Cerebellar ataxia: in neuroblastoma, in children, Mar. 186 Cervical flaps for oral reconstruction, Aug. 617 nodes, metastases in, palpation examination for, Aug. 582 Cervix adenocarcinoma, clear cell, in children, Mar. 234 carcinoma pelvic exenteration in (see Pelvis exenteration, in cervix carcinoma) postirradiation, gross specimen, Dec. 886 Charcot joint, Oct. 730 ankle, Oct. 731 treatment, Oct. 766-767 Charnley-Howorth system, July 469 Charnley “sterile” enclosure: original, July 471 931

Chemotherapy in tongue cancer, Aug. 634-637 in Wilms’ tumor. Mar. 203-204 Chest wall (See also Thoracic) defect. Marlex mesh in. Nov. 823 reconstruction flaps for, latissimus dorsi myocutaneous, May 335 flaps for, muscle and myocutaneous, May 363-364 flans for. results. Mav 379-380 omentum in (see Omentun, greater, transposition, in chest wall reconstruction) Children adenocarcinoma of vagina-cervix, clear cell, Mar. 234 cancer, Mar. 167-242 liver (see Liver cancer, in children) ovarian (see Ovarian cancer, in children) survival, improving, Mar. 169 therapy, long-range effects, Mar. 234-235 Ewing’s sarcoma, extraosseous, Mar. 231 Fibrosarcoma, Mar. 230-231 gastrostomy in, percutaneous endoscopic, Sept. 678-680 germ cell tumors, Mar. 220-221 extragonadal, Mar. 233 gonadoblastoma, Mar. 221 hemangiopericytoma, Mar. 234 hematoblastoma, in boy, Mar. 213 isolation systems for, July 501-502 kidney tumors, Mar. 198-211 leiomyosarcoma, Mar. 233 liposarcoma, Mar. 233 lung cysts, congenital, with tumors, Apr. 286 lymphoma, surgery of, Mar. 227-230 neuroblastoma (see Neuroblastoma, in children) neurofibrosarcoma, Mar. 232-233 rectal prolapse, June 413 rhabdomyosarcoma (see Rhabdomyosarcoma, in children) soft tissue sarcoma, small-cell, Mar 232 solid tumors, malignant, Mar. 167-242 (See also Children, cancer) stromal tumors, Mar. 221-222 synovial sarcoma. Mar. 231-232 932 _

I

teratoma (see Teratoma, malignant, in children) testicular tumors (see Testes, tumors, in children) Wilms tumor (see Wilms tumor, in children) Chopart amputation (see Amputation in diabetic, Chopart) Cigarette smoking: and oropharyngeal cancer, Aug. 569 Circa-matic beds: for isolators, July 507 Circulation impairments in diabetic foot, Oct. 730-731 microcirculation for flaps, May 330 Claudication: in diabetic foot, Oct. 744 Clavicle: radiation osteonecrosis, omental transposition in, Nov. 845 Clean-air, 462-473 Charnley-Howorth system, July 469 surgical microbiologic, July 462-463 “Clean wall unit,” July 515 Colon cancer, pelvic exenteration in, morbidity and survival after, Dec. 899 ischemia after omental transposition, Nov. 855 plication with presacral rectopexy, June 423 transverse, omentum detached from, Nov. 814 Colopexy: in rectal prolapse, June 417-418 Colorectal cancer: pelvic exenteration in, morbidity and survival after, Dec. 899 Computed (see Tomography, computed) Contamination microbial, control in operating room, July 458-499 microbial cross-contamination on wards, control of, July 500-544 operative wound classification and, July 459 Contrast media: for bronchography, Feb. 111-113 CT (see Tomography, computed) cyst bronchogenic (see Bronchogenic cyst)

lung,

congenital, with tumors, children, Apr. 286

in

Cystectomy: post-cystectomy sinus, omental transposition in, Nov. 842 Cystic adenomatoid anomaly of lung, congenital, Apr. 289-297 classification, Apr. 293 lung lobe, left upper, Apr. 266 D “Dancing

eyes:” in neuroblastoma, in children, Mar. 186 Death (see mortality) Decompression gastrostomy, Sept. 678 Decortication (see Empyema, decortication in) Dehiscence: after gastrostomy, Sept. 689-691 Depage gastrostomy, Sept. 675 de Pezser gastrostomy catheter, Sept. 698 Depressor anguli oris myocutaneous flap, Mav 333 Dermal lymphatic metastases: breast, Nov. 825 Descending perineum syndrome, June 407, 408 Devadhar operation: in rectal prolapse, June 430-431 Devascularization: gastric, after omental transposition, Nov. 856 Diabetic amputation in (see Amputation) foot (see Foot, diabetic) gangrene in (see Gangrene) heel ulcer in, Oct. 773-776 leg, ischemia in, assessment, Oct. 734 neuropathy (see Neuropathy, diabetic) plantar abscess in, Oct. 745, 777-781 Diaphragmatic hernia: congenital, Apr. 284 Diarrhea: in neuroblastoma, in children, Mar. 187 Diet: gastrostomy, Sept. 708 Digital systolic pressure, Oct. 739 Diverticulum esophageal, and bronchiectasis, Feb. 144 tracheal, Apr. 258-259 Doppler blood flow detector, Oct. 735 Dragstedt gastrostomy, Sept. 671-672 Drainage in abscess of lung (see Abscess of lung, drainage)

of empyema (see Empyema, drainage) Drug-induced leukopenia: marrow transplant in, July 536-538 Dunphy operation: in rectal prolapse, June416-417 Duodenal perforation: omental transposition in, Nov. 830-831 Dwarf: thanatophoric, Apr. 281 Dysphagia in lung abscess, Jan. 62-65 diagnosis, differential, Jan. 65 pus examination in, Jan. 65 radiography of, Jan. 62-65 Dysplasia: pulmonary, pneumonectomy in, Apr. 251 Dystrophy: asphyxiating thoracic, Apr. 282

E Ear:

neural pathways for referred pain from oral lesion. Aue. 577 Embryology omentum, Nov. Sol-803 respiratory tract (see Respiratory tract, lower, embrylogy of) Emphysema lobar, congenital, Apr. 261-266 in upper lobe, Apr. 263 in upper lobe in newborn, Apr. 264 obstructive, of left upper lobe, Apr. 265 Empyectomy: in empyema, Jan. 31-32 Empyema, Jan. 6-38 amebic with amebic pericarditis, Jan. 79 responding to thoracentesis, Jan. 75 with bronchiectasis, Jan. 28 bronchography of, Jan. 29 clinical manifestations. Jan. 11-12 decortication in, Jan. 27-30 with calcific rind of empyema, Jan. 29 technique, Jan. 30 diagnosis, Jan. 12-13 drainage, closed, Jan. 16-19 drainage, open, Jan. 19-27 anesthesia for, Jan. 22-23 incision, Jan. 23-25 landmarks, Jan. 21-22 position for, Jan. 20-21 postoperative management, Jan. 25-27 933 Y

Empyema (cont.) empyectomy in, Jan. 31-32 historical background, Jan. 6-7 after lung resection, Jan. 32-38 drainage, Jan. 33-35 drainage, “permanent,” Jan. 35-36 sterilization, Jan. 35-36 management, Jan. 14-32 algorithm for, Jan. 15 microbiology of, Jan. lo-11 pathogenesis, Jan. 8-10 pathology, Jan. 7-8 postresectional, management, Jan. 34 radiography of, Jan. 13 thoracis, Jan. 6-38 Endoscopic appe;;nce of completed PEG, Sept. gastrostomy (see Gastrostomy, percutaneous endoscopic) Enolase: neuron specific, in neuroblastoma, in children, Mar. 197-198 Epiglottic lesion: neural pathways referring pain to ear, Aug. 577 Erythroplakic tongue cancer, Aug. 573 Esophageal bronchus, Apr. 267 Esophagobronchial fistula, Jan. 55, Feb. 144 Esophagoplasty: omental transposition in, Nov. 848 Esophagus anastomosis, omental transposition in, Nov. 848 atresia, gastrostomy in, Sept. 686-687 bronchoesophageal fistula, Jan. 55, Feb. 144 diverticulum and bronchiectasis, Feb. 144 embryology, Apr. 254 flaps for, myocutaneous and muscle, May 363 perforation gastrostomy causing, Sept. 704 omental transposition in, Nov. 849 Ewing’s sarcoma: extraosseous, in children, Mar. 231 Extremities (See also Limb) lower (See also Leg) 934

reconstruction, flaps in, results, May 383-385 reconstruction, flaps in, use frequency, May 372 rhabdomyosarcoma, in children, Mar. 177-180 upper, flaps for muscle, May 372-373 myocutaneous, May, 366, 372-373 F Face orofacial-mandibular reconstruction, flaps for, May 361 piece, optically clear, for hip joint replacement, July 456 Fascia: flaps that carry, May 351-352 Fasciocutaneous extended myocutaneous flap, May 347-349 Feeding (see Gastrostomy, feeding) Femoral neck fracture: pinning of, isolator to reduce postoperative wound infection after, July 498 Ferritin: serum, in neuroblastoma, in children, Mar. 197-198 Fever Lassa, July 538-539 in neuroblastoma, in children, Mar. 187 Fibrosarcoma: in children, Mar. 230-231 Fistula arteriovenous, pulmonary, Apr. 299-301 bronchobiliary, Apr. 268 bronchoesophageal, Jan. 55, Feb. 144 bronchopleural (see Bronchopleural fistula) esophagobronchial, Jan. 55, Feb. 144 gastrocutaneous (see Gastrostomy, gastrocutaneous fistula after) pelvic (see Pelvis, fistula) prostatorectal, omental transposition in, Nov. 841-842 vesicovaginal (see Omentum, greater, transposition, in vesicovaginal fistula) vesicovaginorectal, omental transposition in, Nov. 840-841 Flaps cervical, for oral reconstruction, Aug. 617

muscle (see Muscle flap) myocutaneous (see Myocutaneous flap) pectoral, for oral reconstruction, Aug. 617 Foley, catheter: for gastrostomy, Sept 698 Foot diabetic, Oct. 729-788 angiodilatation in, Oct. 748-750 arterial reconstruction in, distal, act. 753 arterial reconstruction in, proximal, Oct. 750-753 arteriography in, Oct. 747-748 circulation impairments in, Oct. 730-731 claudication in, Oct. 744 clinical decision making, Oct. 741-743 clinical problem, Oct. 730-734 foot perfusion in, Oct. 738-739 footwear for, Oct. 732 foreign bodies in, Oct. 732 gangrene in (see Gangrene) healing of lesions, Oct. 759-761 history, Oct. 730 iceberg problem of, Oct. 779 long-term view, Oct. 784 neuropathy (see Neuropathy, diabetic, of foot) nhilosonhv. Oct. 783-784 prophyiac%c care, Oct. 765-766 pulse volume recordings in, Oct. 739-740 rest pain in, Oct. 741-742 rest pain in, criteria for, Oct. 741-742 revascularization in, Oct. 743-759 segmental limb pressures in, Oct. 735-738 surgical care, Oct. 759-781 sympathectomy in, Oct. 781-783 tibia1 vessel reconstruction in, Oct. 754-756 treatment of injuries, Oct. 766-781 vein bypass in, in situ, Oct. 753-754 vein bypass in, in situ, new horizons, Oct. 754 vein refinements, reversed, Oct. 756-759 flaps muscle, May 343, 372 muscle, results, May 385 myocutaneous, May 340-341, 372

perfusion in diabetic, Oct. 738-739 Footwear: for diabetic, Oct. 732 Forefoot in diabetic amputation, Oct. 746 gangrene, treatment, Oct. 769 extensive, Oct. 769-772 Foregut derivatives, anomalous bronchi arising from, Apr. 266-268 duplication and bronchiectasis, Feb. 144 Foreign bodies: in diabetic foot, Oct. 732 Foster frames: for isolator, July 507 Fracture femoral neck, pinning, isolator to reduce postoperative wound infection after, July 498 in neuroblastoma, in children, Mar. 187 G Gangrene in diabetic forefoot, treatment, Oct. 769 extensive, Oct. 769-772 loss of entire foot, Oct. 772 plantar abscess and, Oct. 745 toe, Ott, 779 treatment, Oct. 768-769 Gastric (see Gastrointestinal; Stomach) Gastrocnemius myocutaneous flap, May 340 Gastrocolic omentum, Nov. 796 Gastrocutaneous fistula (see Gastrostomy, gastrocutaneous fistula after) Gastroepiploic artery left, Nov. 798, 816 right, Nov. 798 Gastroesophageal reflux: and gastrostomy, Sept. 687-688 Gastrointestinal (See also Intestine; Stomach) anastomoses, omental transposition for, Nov. 831 irradiation injury, omental transposition in, Nov. 833 surgery, omental transposition in, Nov. 830-833 Gastrophrenic ligament, Nov. 796 Gastrosplenic omentum, Nov. 797 Gastrostomy, Sept. 661-719 administration of improper feedings complicating, Sept. 695-696 Beck-Jianu, Sept. 675 bowel perforation due to, Sept. 704 935

Gastrostomy Ccont.l “button,” Sept. 696, 697 catheter, Sept. 668-674 complications related to, Sept. 697-706 delay in reintroduction of, Sept. 696 deterioration, Sept. 702 Foley, Sept. 698 improper placement, Sept. 693 migration, external, Sept. 704 migration, internal, Sept. 703-704 reinsertion, trauma during, Sept. 696-697 traditional, Sept. 706 complications, prevention and management, Sept. 688-706 controversial aspects, Sept. 683-688 decompression, Sept. 678 dehiscence after, Sept. 689-691 Depage, Sept. 675 development, landmarks in, Sept. 661-664 devices, newer, Sept. 707-708 diet, Sept. 708 discomfort, Sept. 701 Draastedt. Sent. 671-672 in esophageal-atresia, Sept. 686-687 esophageal perforation due to, Sept. 704 feeding comparison of types, Sept. 676 indications for, Sept. 677-678 techniques, Sept. 708, 709 formation of channel from anterior gastric wall, Sept. 663-664 formation of gastric “cone,” Sept. 663 formation of tube from bowel segment, Sept. 664 formation of tube from flap of gastric wall, Sept. 664 gastrocutaneous fistula after excision of, Sept. 705 persistent, Sept. 704-705 gastroesophageal reflux and, Sept. 687-688 granulation tissue complicating, Sept. 697-698 hemorrhage after, Sept. 691-692 Hirsch, Sept. 675 historical perspective, Sept. 661-668 indications, Sept. 677-678 infection after, Sept. 692 Janeway, Sept. 674-676 936

operative photograph, Sept. 676 jejunostomy vs., Sept. 685-686 leakage, Sept. 694,.698-701 stoma relocation for, Sent. 702 moniliasis after, Sept.‘694-695 moral questions, Sept. 708-710 nasogastric tube vs., Sept. 683-685 organ injury during, Sept. 693 in pelvic cancer, Dec. 918 percutaneous endoscopic, Sept. 667 in adults, Sept. 681-683 authors’ experience with, Sept. 678-683 catheter, Sept. 668 in children, Sept. 678-680 completed, endoscopic appearance, Sept. 669 external appearance one month after completion, Sept. 669 techniaue. Sent. 672-674 pitfalls, avoiding, Sept. 705-706 postural problems after, Sept. 704 prolapse, Sept. 694 psychological problems after, Sept. 704 removal, inadvertent, Sept. 703 skin irritation after, Sept. 694-695 Stamm, Sept. 668-671 completed, Sept. 671 stoma complications related to, Sept. 694-697 practical considerations, Sept. 706-708 relocation for leakage, Sept. 702 stomach separation from abdominal wall after, Sept. 689 stomach wall injury and, posterior, Sept. 692 techniques, Sept. 668-676 complications related to, Sept. 689-693 evolution of, Sept. 664-667 tube introducer, Sept. 699 latex, deterioration of, Sept. 695 plugging, Sept. 695 types of, Sept. 662 ventral hernia after, Sept. 689-691 well-healed, complication-free, Sept. 691 without catheter, Sept. 674-676 without celiotomy, Sept. 664 Witzel, Sept. 671 wound separation after, Sept. 689-691 >auntlet surgical isolator systems, July 494-498

clinical

experience with, July 494-498 for neurosurgical procedures, July 498 for orthopedic procedures, July 494-498 Genetic factors: in Wilms tumor, Mar. 198-199 Genitalia: muscle and myocutaneous flaps for, May 369-370 Genitourinary tract rhabdomyosarcoma: in children, Mar. 174-177 Germ cell tumors, in children, Mar. 220-221 extragonadal, Mar. 233 Germfree animal operating unit, July 481 Gluteus maximus myocutaneous flap, May 337 Gonadoblastoma: in children. Mar. 221 Gracilis myocutaneous flap, May 338 Graciloplasty: in rectal prolapse, June 438-439 Graft flap (see Flap) omentum free vascularized, in head and neck reconstruction, Nov. 845-847 split thickness skin, Nov. 827 vein, reversed, in diabetic foot, Oct. 756-759 Graham operation: in rectal prolapse, June 416-417 Granular cell myoblastoma: tongue, Aug 639 Granulation tissue complicating gastrostomy, Sept. 697-698 after omentum transposition in chest wall reconstruction, Nov. 826 Groin flaps for, muscle and myocutaneous, May 370 results, May 382 use frequency, May 370 omental transposition to, Nov. 851-852

H Hamartoma: lung, Apr. 297-298 Hand: omental transposition to, Nov. 853

Head reconstruction flaps for, muscle and myocutaneous, May 358-363 flaps for, muscle and myocutaneous, results, May 377-379 flaps for, muscle and myocutaneous, use frequency, May 360 omental transposition in, Nov. 843-847 omental transposition in, free vascularized omental grafts, Nov. 845-847 rhabdomyosarcoma, in children, Mar. 181-182 Headpiece: with optically clear face piece for hip joint replacement, July 465 Healing: of lesions in diabetic foot, Oct. 759-761 Heart surgery: ultraclean air in, July 473 Heel ulceration: in diabetic, Oct. 773-776 Hemangioma: tongue, Aug. 639 Hemangiopericytoma: in children, Mar. 234 Hematoma: after omental transposition, Nov. 855 Hemisoleus muscle flap, May 343 myocutaneous flap, fasciocutaneous extension, May 350 Hemophilus infkenzae: in pneumonia, Jan. 53 Hemoptysis: and lung abscess, Jan. 63 Hemorrhage after gastrostomy, Sept. 691-692 after omental transposition, Nov. 855 subperiosteal, in neuroblastoma, in children, Mar. 187 Hepatic (see Liver) Hepatoblastoma: in boy, Mar. 213 Hepatomegaly: in neuroblastoma, in children, Mar. 186 Hernia diaphragmatic, congenital, Apr. 284 incisional, after omental transposition, Nov. 855 perineal, prevention and repair, Dec. 918 ventral, after gastrostomy, Sept. 689-691 Herniation: of lung, CT of, Apr. 251 Hirsch gastrostomy, Sept. 675 937

Hodgkin’s

disease: surgery of, in children, Mar. 227-228 Homovanillylic acid: in neuroblastoma, in children, Mar. 197 Humidity: and microbial crosscontamination in wards, July 501 Hypertension: in neuroblastoma, in children, Mar. 187 Hypoplasia (see Pulmonary, hypoplasia)

Iceberg

problem: of diabetic foot, Oct. 779 Iliac artery stenosis: angiodilatation, in diabetic, Oct. 749 Immunodeficiency isolators for patients with, July 531-536 syndrome, acquired, isolators in, July 540 Immunology: of omentum, Nov. 803-805 Immunotherapy: of tongue cancer, Aug. 637 Incontinence: after rectal prolapse surgery, problem of, June 442-445 Infection after gastrostomy, Sept. 692 highly infectious diseases, containment isolation for patients with. Julv 538-539 isolators for containment of patients with, July 526 nosocomial (see Nosocomial infection) postoperative wound (see Postoperative wound infection) Intelligence: and pelvic exenteration, Dec. 883 Intensive care (see Surgical intensive care units) Intestine (See also Gastrointestinal) obstruction after omental transposition, Nov. 855 small (see Bowel, small) Intra-abdominal applications: of omental transposition, Nov. 830,833-838 Intussusception of rectum, June 406 reversed, June 430 Irradiation (see Radiation) 938

Ischemia colonic, after omental transposition, Nov. 855 in diabetic leg, assessment of, Oct. 734 Ischemic wounds flaps for, muscle and myocutaneous, May 358 radiation, closed with myocutaneous flap, May 359 Ischial pressure sore: myocutaneous flap closure, May 369 Isolators, July 479-499 for ambulance transportation of patients, July 513 bed, July 508 picture of, July 507 Trexler-Vickers, July 510, 511 by van der Waaij, July 518 whole-body, July 501-507 built around special beds, July 506-508 for burn patients, July 521-526 children isolation svstem. Julv 501-502 ” ’ ” Circa-matic beds for, July 507 containment, for patients with highly infectious diseases, July 538-539 after femoral neck fracture pinning, July 498 Foster frames for, July 507 historical background, brief, July 479-481 in immunodeficiency patients, July 531-536 for infected patient containment, July 526 Kranz, July 502-506 diagram-of, July 506 -1aminar airflow combinations, July 514-521 laminar cross-flow nursing, with mother visiting, July 517 for leukemia patients, July 527-531 Levenson, July 502-506 diagram of, July 506 Life-Island, July 501 picture of, July 502 for lymphoma patients, July 531 after marrow transplant, July 536-538 for necropsies, hazardous, July 539 partial-body, July 507-508 enclosing leg, July 512 physical barrier, July 479-499 on wards, July 500-512

room, July 507 specialized protective environments, clinical experience with, July 521-541 study of, major multicenter, July 469-473 Stryker frames for, July 507 suit furnished by NASA, July 505 surgical intensive care unit (see Surgical intensive care units) surgical, system chutes for discarded equipment, July 492 clean-contaminated operations, July 489 clean operations with, July 489 conditioned air for members of surgical team, July 492 gauntlet (see Gauntlet surgical isolator systems) half-suit. Julv 481-488. 502-506 half-suit; clinical experience with, July 488-494 helmet-jacket (see half-suit above) interior during operation, July 486 ISOP, July 494 passing autoclaved supplies into isolator, July 491 -split-seam transfer. Julv 488 for surgical procedures,“general, July 499 Trexler-Vickers, July 494, 496-499,506 view of operation by anesthetist, July 487 transfer whole-body, July 508-512 transport, for long-distance patient transportation, July 514 Trexler, July 502-506 diagram of, July 506 ulm flexible film plastic, July 503 ISOP surgical isolator, July 494 Ivalon sponge repair: in rectal prolapse, June 427-429 .T

Janeway gastrostomy, Sept. 674-676 operative photograph, Sept. 676 Jejunostomy: vs. gastrostomy, Sept. 685-686 Jeune’s syndrome, Apr. 282 Joint ankle (see Ankle, joint) Charcot (see Charcot joint) hip, replacement, headpiece with optically clear face piece for, July 465

K Kidney

tumors: in children, Mar. 198-211 Klebsiella: causing lung abscess, Jan. 52 Knee amputation in diabetic above-knee, Oct. 773 below-knee, Oct. 773 below-knee, vascular laboratory criteria for primary healing of, Oct. 764 reconstruction, flaps for muscle and myocutaneous, May 370 open knee, May 371 Kranz Isolator, July 502-506 diagram of, July 506

L Laennec’s monograph, Feb. 99-100 Laminar airflow -barrier combinations, July 514-521 portable units, July 512-514 in prevention of postoperative wound infections, effectiveness of, July 466-468 rooms, July 512-514 with “anteroom,” July 516 of surgical intensive care units, July 544 ultraclean air, July 463-466 Laminar cross-flow nursing isolator: mother visiting, July 517 Lassa fever, July 538-539 Latex gastrostomy tube: deterioration of, Sept. 695 Latissimus dorsi myocutaneous flap, May 334-336 Leather’s intraluminal valve cutter, act. 755 Leg (see also Extremities, lower) diabetic, ischemia in,. assessment, Oct. 734 distal, muscle flap, May 343 lower third, distal anastomoses to vessels in, in diabetic foot. Oct. 758 flaps for muscle, May 371 muscle, results, May 385 myocutaneous, May 371 Leiomyosarcoma: in children, Mar. 233 939

Leukemia isolators for patients with, July 527-531 marrow transplant in, July 536-538 Leukopenia: drug-induced, marrow transplant in, July 536-538 Levator ani plication in rectal prolapse, Jun 416 in rectal prolapse, June 405 scapulae muscle flap, May 342 Levenson Isolator, July 502-506 diagram of, July 506 Lienorenal ligament. Nov. 797 Life-Island Isolator, July 501 picture of, July 502 Ligament gastrophrenic, Nov. 796 lienorenal, Nov. 797 Light: ultraviolet, in prevention of nosocomial infection, July 474-479 Limb (See also Extremities) pressures, segmental, in diabetic foot, act. 735-738 salvage in diabetic foot, Oct. 744-747 Lip reconstruction, flaps for lower lip, May 362 muscle and myocutaneous, May 363 Liposarcoma: in children, Mar. 233 Liver cancer, in children, Mar. 211-216 diagnosis, Mar. 211-212 therapy, Mar. 212-214 results, Mar. 215-216 Loygue procedure, June 420 Lung (See also Pulmonary) abscess (see Abscess of lung) absent, Apr. 274-277 agenesis, Apr. 274-277 unilateral, Apr. 276 amebiasis, Jan. 73-80 anomalies, congenital, Apr. 251-314 aplasia, Apr. 274-277 cyst, congenital, with tumors, in children, Apr. 286 cystic adenomatoid anomaly, congenital, Apr. 289-297 classification, Apr. 293 cystic, upper lobe, Apr. 266 disease 940

parenchymal, Apr. 285-298 suppurative, Jan. 5-89 emphysema (see Emphysema) hamartoma, Apr. 297-298 herniation, CT of, Apr. 251 left, congenital bronchiectasis of, Apr. 262 lobar buds, Apr. 254 resection anatomical limits of, Feb. 131-133 for bronchiectasis (see Bronchiectasis, resection) bronchopleural fistula after, Jan. 36-38 empyema after (see Empyema, after lung resection) in lung abscess, Jan. 72-73 sequestration (see Sequestration) small, Apr. 274-277 tumors, Apr. 297-298 Lymph nodes cervical, metastases in, palpation examination for, Aug. 582 contralateral, treatment for massive tongue cancer, Aug. 615-616 Lymphangiectasia, Apr. 301-302 Lymphatics: of omentum. Nov. 800-801 Lymphedema: omental transposition in, Nov. 852-853 Lymphocytes: of omentum, Nov. 804 Lymphoma Hodgkin’s, surgery of, in children, Mar. 227-230 malignant, isolators for patients with, July ” 531 non-Hodgkin’s, surgery of, in children, Mar. 227-230 M Macrophages: omentum, Nov. 803-804 Ma1 perforans, diabetic, Oct. 731-732 treatment, Cct. 767-768 Malformations (see Anomalies) Malignancy (see Cancer) Mandible forces exerted by temporalis, masseter, and pterygoid muscles on, Aug. 630 reconstruction, flaps for, May 361 resection in tongue cancer, Aug. 613-615 tongue base, Aug. 631 with tongue resection, Aug. 612-613

Marlex mesh in chest wall defect, Nov. 823 rectopexy, June 420 Marrow cells cultured from, in neuroblastoma, labeling index of, in children, Mar. 197 transplantation isolators for patients after, July 536-538 in neuroblastoma, in children, Mar. 195-196 Masseter muscle: forces exerted on mandible by, Aug. 630 Mast cells: omentum, Nov. 804-805 Mediastinum anterior, muscle and myocutaneous flaps for, Mav 365 reconstruction, results with flaps, May 379-380 tumors in neuroblastoma, in children, Mar. 187 Mental status: and pelvic exenteration, Dec. 883 Metastases in cervical nodes, palpation examination for, Aug. 582 dermal lymphatic, breast, Nov. 825 in neuroblastoma, in children, Mar. 187 omental, Nov. SOS-810 in Wilms tumor, in children, Mar. 208 Metronidazole, Jan. 79 in amebic empyema, Jan. 75 Microbial contamination, control in operating room, July 458-499 cross-contamination, control on wards, July 500-544 Microcirculation: for flaps, May 330 Mill’s valvulotome, Oct. 755 Moniliasis: after gastrostomy, Sept. 694-695 Mortality in bronchiectasis surgery, Feb. 141 of omental transposition, Nov. 857 in oropharyngeal cancer, and smoking, Aug. 569 in rhabdomyosarcoma, in children, influence of site, Mar. 176 Moschowitz operation: in rectal prolapse, June 414-415 Motor innervated flap, May 354, 355 Mouth (see Oral) Muscle flap (see below)

masseter, forces exerted on mandible by, Aug. 630 pterygoid, forces exerted on mandible by, Aug. 630 temporalis, forces exerted on mandible by, Aug. 630 r fiuscle flap, May 321-393 anatomy, May 324-330 applications, regional, May 358-373 for bronchopleural fistula, Jan. 36-38 complications, May 376-385 rate, May 373-379 compound flaps, May 351-352 for contaminated wounds, May 356 design, May 374 refinements, May 343-355 donor defect, May 374 example, May 322 flap size augmentation, surgical and pharmacologic, May 331 foot intrinsic, May 343 results, Mav ” 385 functional flaps, May 353-355 hemisoleus, May 343 historv. Mav 323-324 inset of, May 375 intramuscular vascular territories, May 325 for ischemic wounds, May 358 island pedicle transfer, May 349 leg distal, May 343 results with, May 385 levator scapulae, May 342 for massive defects, May 358 microcirculatory physiology, May 330 microvascular transfer, May 349-351 motor innervated, May 354, 355 muscle kinesiology, May 331 physiology, May 330-331 postoperative care, May 376 preservation of donor motor function, May 355 principal, May 341-343 for problem wounds, May 356-358 reversed, May 347, 348 rhomboideus major, May 342 sartorius, May 342 sensory innervated, May 354-355 serratus anterior, May 342 soleus, May 343 for tibia. Mav 344 split flaps,’ segmentally, May 345-347 941

Muscle flap (cont.) success rate, May 376-385 temporalis, May 341 for tibia and ankle in osteomyelitis, May 357 transfer, May 375 vascular supply, May 324-325, 326 vastus lateralis, May 342 wound preparation for, May 373-374 for wounds with dead space that cannot be collapsed. Mav 357-358 Mycobacterium tuberculosis: in lung abscess, Jan. 56 Myoblastoma: granular cell, tongue, Aug. 639 Myocutaneous flap, May 321-393 anatomy, May 324-330 applicc:o;;3 regional, May biceps femoris, May 338 complications, May 376-385 rate, May 378-379 compound flaps, May 351-352 carrying vascularized bone, May 352 carrying vascularized tendon, May 353 for contaminated wounds, May 356 depressor anguli oris, May 333 design, May 374 refinements, May 343-355 donor defect, May 374 example, May 322 external oblique, May 336-337 fasciocutaneous extended, May 347-349 flap size augmentation, surgical and pharmacologic, May 331 of foot. Mav 340-341 functional kaps, May 353-355 gastrocnemius, May 340 gluteus maximus, May 337 gracilis, May 338 hemisoleus, fasciocutaneous extension, May, 350 history, May 323-324 inset of, May 375 for ischemic wounds, May 358 island pedicle transfer, May 349 latissimus dorsi, May 334-336 major flaps, May 328-329 for massive defects, May 358 microcirculatory physiology, May 330 microvascular transfer, May 349-351 942

motor innervated, May 354, 355 myocutaneous perforators, May 325-326,327 myocutaneous territories, May 326-330 oribucularis oris, May 333 pectoralis major, May 334 major, segmentally split, May 346 in tongue base cancer, Aug. 632 physiology, May 330-331 platysma, May 333-334 postoperative care, May 376 prese-ovation of donor motor function, May 355 principal, May 332-341 for problem wounds, May 356-358 for radiation wound closure, ischemic, May 359 rectus abdominis, May 336 rectus femoris, May 338 reversed, May 347 sensory innervated, May 354-355 soleus, May 340 split flaps, segmentally, May 345-347 sternomastoid, May 334 success rate, May 376-385 ten most frequently used flaps, May 332 tensor fascia lata, May 337-338 from thigh, May 340 transfer. Mav 375 trapezius, May 334 upper-extremity, May 336 vastus medialis, May 338-339 wound preparation for, May 373-374 for wounds with dead space that cannot be collapsed, May 357-358 N Nasogastric tube: vs. Sept. 683-685 Neck dissection for tongue 607-610 reconstruction flaps for, muscle myocutaneous, flaps for, muscle myocutaneous, 377-379 flaps for, muscle myocutaneous, May 360

gastrostomy,

cancer,

Aug.

and May 358-363 and results, May and use frequency,

omental transposition in, Nov. 843-847 omental transposition in, free vascularized omental grafts, Nov. 845-847 rhabdomyosarcoma, in children, Mar. 181-182 Necrosis: omental, after transposition, Nov. 854 Neoplasia (see Tumors) Nephrectomy: partial, omental transposition in, Nov. 843 Nephroblastoma (see Wilms tumor) Nerves: of omentum, Nov. 801 Netherlands system; July 517-519 Neural pathways: of oral lesion referring pain to ear, Aug. 517 Neuroblastoma, in children, Mar. 184-198 age and, Mar. 196 clinical aspects, general, Mar. 188-189 clinical syndromes observed in, Mar. 186-187 CT in, Mar. 192 diagnosis, Mar. 185 enolase in, neuron specific, Mar. 197-198 ferritin and, serum, Mar. 197-198 labeling index of cell cultures from marrow, Mar. 197 nutrition in, state of, Mar. 197 pathology, Mar. 184-185 radiotherapy of, total body, Mar 195-196 stage I, Mar. 189-190 stage II, Mar. 189-190 stage III, Mar. 190-191 stage IV, Mar. 194-195 prognostic factors in, Mar. 196-198 stage IVa, Mar. 192-194 staging of, Mar. 185-188 surgery of, Mar. 195-196 surgical variables in, Mar. 196 VMA/HVA ratio in. Mar. 197 Neurofibrosarcoma: in children, Mar. 232-233 Neuropathic ulcerations of foot, Oct. 731-732 treatment, Oct. 767-768 Neuropathy, diabetic, of foot, Oct. 730-731 clinical decision-making, Oct. 741-742 criteria for, Oct. 742

Neurosurgical procedures: gauntlet surgical isolator systems for, July 498 Newborn emphysema of, lobar, Apr. 264 gastrostomy and jejunostomy in, Sept. 686 tracheal atresia, Apr. 257 Nosocomial infection, July 458-558 isolators in (see Isolators) operative wound classification by increasing risk, July 459 prevention, July 458-558 Notaras variation: of Thiersch procedure, June 434 Nutritional state: and neuroblastoma, in children, Mar. 197

0 Omentectomy, Nov. 808-812 in gastric cancer, Nov. 812 in ovarian cancer, Nov. 810-812 Omentocystoplasty, Nov. 842 Omentoureterostomy: cutaneous, Nov. 843 Omentum gastrocolic, Nov. 796 gastrosnlenic. Nov. 797 Omentum, greater, Nov. 795-865 absorption, Nov. 807 adhesion, Nov. 805-807 anatomy, Nov. 796-797 angiogenesis, Nov. 805 apron, Nov. 814 division of, Nov. 815-818 arterial supply, Nov. 800 blood supply to, Nov. 798-800 capillaries in (in rabbit), Nov. 796 detachment from stomach, Nov. 814-815 detachment from transverse colon, Nov. 814 elongation, Nov. 816 embryology, Nov. 801-803 function, Nov. 803-807 histology, Nov. 797-798 immunology, Nov. 803-805 lymphatics, Nov. 800-801 lymphocytes, Nov. 804 macrophages, Nov. 803-804 mast cells, Nov. 804-805 metastases, Nov. 808-810 nerves, Nov. 801 in oncology, Nov. 808-812 pedicle, Nov. 817 in surgery, Nov. 808-812 transposition, Nov. 813-818 943

Omentum, greater (cont.) in abdominal wall reconstruction, Nov. 829-830 to arm, Nov. 853 to axilla, Nov. 849-850 in bowel prolapse, small, Nov. 838 in brachial plexopathy, radiationinduced. Nov. 850-851 breast cancer recurrence after, Nov. 856 in breast reconstruction, Nov. 828-829 in bronchopleural fistula, Nov. 849 as carotid cover, Nov. 843-844 in chest wall reconstruction, Nov. 818-829 in chest wall reconstruction, assessment, Nov. 821 in chest wall reconstruction, end result, Nov. 828 in chest wall reconstruction, preparation, Nov. 821 in-chest wall reconstruction, technique, Nov. 822-828 colonic ischemia after, Nov. 855 complications, Nov. 853-856 in duodenal perforation. Nov 830-831 in esophageal anastomosis, Nov. 848 in esophageal perforation, Nov. 849 in esophagoplasty, Nov. 848 future applications, Nov. 853 gastric devascularization after, Nov. 856 in gastric perforation, Nov. 830-831 gastric stasis after, Nov. 855 in gastrointestinal anastomoses, Nov. 831 in gastrointesinal irradiation injury, Nov. 833 for gastrointestinal reinforcement, Nov. 831 for gastrointestinal reinforcement, free graft reinforcement, Nov. 831-832 for gastrointestinal reinforcement, pedicled omental, Nov. 832 in gastrointestinal surgery, NOV. 830-833 to groin, Nov. 851-852 to hand, Nov. 853

944

in head reconstruction, Nov. 843-847 in head reconstruction, free vascularized omental grafts, Nov. 845-847 hematoma after, Nov. 855 hemorrhage after, Nov. 855 hernia after, incisional, Nov. 855 intestinal obstruction after, Nov. 855 intra-abdominal applications, Nov. 830, 833-838 in lymphedema, Nov. 852-853 mortality of, Nov. 857 in neck reconstruction, Nov. 843-847 in neck reconstruction, free vascularized omental grafts, Nov. 845-847 necrosis after, Nov. 854 in nephrectomy, partial, Nov. 843 in pelvis exenteration, Nov. 837-838 in pelvis fistula, Nov. 839-843 in pelvis fistula prevention, Nov. 841 in pelvis reconstruction, Nov. 834, 835, 836 in pharyngostomy, Nov. 844-845 in post-cystectomy sinus, Nov. 842 in prostatorectal fistula, Nov. 841-842 in reconstructive surgery, Nov. 812-813 in reconstructive surgery, applications of, Nov. 818 in rectal carcinoma, locally advanced. Nov. 836-837 in rectal surgery, Nov. 834-836 in thoracic surgery, Nov. 847-849 tumor recurrence after, Nov. 856 in ureterolysis, Nov. 842 in urology, Nov. 839-843 venous thrombosis after, Nov. 854 in vesicovaginal fistula, Nov. 839-840 in vesicovaginal fistula, assessment, Nov. 839 in vesicovaginal fistula, preparation, Nov. 839 in‘vesicovaginal fistula, technique, Nov. 839-840 in vesicovaginorectal fistula, Nov. 840-841Oncology: greater omentum in, Nov. 808-812

Operating

room: microbial contamination control in, July 458-499 Operating unit: germfree animal, July 481 Operative wounds: classification of, July 459 Opso-myoclonus: in neuroblastoma, in children, Mar. 186 Oral cancer radiotherapy, complication rate, Aug. 598 sites of, Aug. 573 reconstruction, cervical and pectoral flaps for, Aug. 617 sphincter, muscle and myocutaneous flaps for, May 363 Orbicularis oris myocutaneous flap, May 333 Orbit: rhabdomyosarcoma, Mar. 182 Orofacial-mandibular reconstruction: flaps for, May 361 Oropharynx aspiration from, in lung abscess, Jan. 41-42 cancer, and smoking, Aug. 569 Orthopedic procedures gauntlet isolators for, July 494-498 major, ultraviolet light for operating room, July 477 Orthosis: for transmetatarsal amputation, Oct. 776 Osteomyelitis: tibia and ankle in, muscle flap closure, May 357 Osteonecrosis: of clavicle, radiation, omental transposition in, Nov. 845 Ovarian cancer in children, Mar. 220-223 adjunctive therapy, Mar. 223 surgery of, Mar. 222-223 omentectomy in, Nov. 810-812 P Pain referred, to ear, from oral lesion, neural pathways for, Aug. 577 rest, in diabetic foot, Oct. 741-742 criteria for, Oct. 741-742 Paraplegia: in neuroblastoma, in children, Mar. 186 Paratesticular site: of rhabdomyosarcoma, in children, Mar. 180-181

Partial barrier systems Charnlev-Howorth, Julv ” 469 in nosocomial infection prevention, July 462-473 Patella: flaps for, muscle and myocutaneous, May 370 Patellar tendon defects: flap in reconstruction, May 371 Pectoral flap: for oral reconstruction, Aug. 617 Pectoralis major myocutaneous flap, May 334 segmentally split, May 346 myocutaneous flap for tongue base cancer, Aug. 632 Pedal artery: anatomy, Oct. 756 PEG (see Gastrostomy, percutaneous endoscopic) Pelite: lining molded polypropylene prosthesis, Oct. 771 Pelvis bony, resection, Dec. 916-917 cancer gastrostomy in, Dec. 918 operations aimed at empty pelvis, Dec. 915-916 pathology, Dec. 877-878 pelvis exenteration in (see Pelvis extenteration, in pelvic cancer) pelvis resection in, bony, Dec. 916-917 rectal reconstruction in, Dec. 912-913 surgery in, ultraradical, Dec. 875-927 surgery in, ultraradical (See aZso Pelvis extenteration, in pelvic cancer) urinary diversion in, Dec. 908-912 vagina reconstruction in, Dec. 914-915 defects, obliteration of, Dec. 917-918 empty, operations aimed at, Dec. 915-916 exenteration (see below) fistula omental transposition in, Nov. 839-843 prevention using omental transposition, Nov. 841 mass in neuroblastoma, in children, Mar. 186 reconstruction, omental transposition in, Nov. 834, 835, 836

945

Pelvis exenteration anterior, Dec. 879, 881 in cervix carcinoma, Dec. 885-894 complications, Dec. 905 complications, postoperative, Dec. 903 determination of operability at exploration, Dec. 888-890 palliative, Dec. 893-894 preoperative assessment of lesion, Dec. 885-888 results, Dec. 890-893 in colorectal cancer, morbidity and survival after, Dec. 899 indications, Dec. 884-885 lesions treated by, Dec. 879 omental transposition in, Nov. 837-838 in pelvic cancer age and, Dec. 882-883 anterior, Dec. 908, 909 assurance of localized disease, Dec. 883 attitude and, Dec. 883 complications, Dec. 902-907 complications, early, Dec. 902-906 complications, late, Dec. 906-907 general medical assessment, Dec. 884 intelligence and, Dec. 883 mental status and, Dec. 883 patient selection factors, Dec. 882-884 perineal hernia, prevention and repair, Dec. 918 posterior, Dec. 908 quality of life after, Dec. 902 technical factors, Dec. 878-882 pelvis after, illustration, Dec. 880 posterior, Dec. 879-880, 881 in rectum carcinoma determination of operability at exploration, Dec. 897-899 palliative, Dec. 901-902 preoperative assessment of pelvic lesion, Dec. 894-897 radiotherapy and, adjuvant, Dec. 918-921 results, Dec. 899-901 total, Dec. 879 variations, Dec. 881 Pericarditis: amebic, with amebic empyema, Jan. 79 Perineum defects, obliteration of, Dec. 917-918 946

descending perineum syndrome, June 407,408 hernia, prevention and repair, Dec. 918 reconstruction, flaps for results, May 382 use frequency, May 370 rectopexy in rectal prolapse, June 439-440 rectosigmoidectomy in rectal prolapse, June 434-437 Peroneal artery: in in situ bypass in diabetic foot, Oct. 757 Pharyngeal groove, Apr. 254 Pharyngolaryngoesophagectomy: omental transposition after, Nov. 844 Pharyngostomy: omental transposition in, Nov. 844-845 Photoplethysmograph: for digital systolic pressure, Oct. 739 Physical barrier isolators, July 479-499 on wards, July 500-512 Plantar abscess: in diabetic, Oct. 745, 777-781 Platysma myocutaneous flap, May 333-334 Pleural space: suppurative diseases of, Jan. 5-89 Pleuropulmonary amebiasis, Jan. 73-80 Plexopathy: radiation-induced brachial, omental transposition in, Nov. 850-851 Pneumatocele: staphylococcal, Jan. 54 Pneumonectomy: in pulmonary dysplasia, Apr. 251 Pneumonia aspiration anaerobic, sequelae, Jan. 42 bronchography in, Jan. 40 bacteria in, gram-negative, Jan. 51 destructive bronchiectasis and, Feb. 144 chronic, Jan. 46-47 gram-positive, Jan. 51-53 Hemophilus influewae in, Jan. 53 in lung abscess, Jan. 49-53 etiology, Jan. 49-50 pathogenesis, Jan. 50-51 pathology, Jan. 51-53 suppurative, radiography of, Jan. 45 Pneumonitis, Jan. 43 Pneumonostomy: closed-tube, failure of. Jan. 57

Polypropylene prosthesis: molded, lined with Pelite, Oct. 771 Polyvinyl alcohol sponge repair: of rectal prolapse, June 427-429 Portal venous system, Nov. 799 Post-cystectomy sinus: omental transposition in, Nov. 842 Postoperative wound infection, July 458-499 Duke Medical Center Study, July 476 after femoral neck fracture pinning, wound isolator for, July 498 incidence, July 475 laminar airflow in prevention of, effectiveness of, July 466-468 Postural problems: after gastrostomy, Sept. 704 Potter’s syndrome: with pulmonary hypoplasia, Apr. 280 Prematurity: gastrostomy in esophageal atresia in, Sept. 687 Prenatal ultrasound: in congenital cystic adenomatoid malformation of lung, Apr. 295 Presacral rectopexy (see Rectopexy, presacral) Pressure sore ischial, myocutaneous flap closure of, May 369 reconstruction, flaps for, muscle and mvocutaneous. Mav 367-369 resuhs, May 382-383 use frequency, May 368 Prostate: rhabdomyosarcoma, in children, Mar. 174-177 Prostatorectal fistula: omental transposition in, Nov. 841-842 Prosthesis Chopart amputation, Oct. 772 in place, Oct. 773 polypropylene, molded, lined with Pelite, Oct. 771 Psychological problems: of gastrostomy, Sept. 704 Pterygoid muscle: forces exerted on mandible by, Aug. 630 Puborectalis sling operation: in rectal prolapse, June 431-432 Pulmonary (See also Lung) arteriovenous fistula, Apr. 299-301 artery agenesis, Apr. 303 dysplasia, pneumonectomy in, Apr. 251 hypoplasia primary, Apr. 278-284 secondary, Apr. 279-284

secondary, conditions associated with, Apr. 279 secondary, with Potter’s syndrome, Apr. 280 lymphangiectasia, Apr. 301-303 primordium, Apr. 254 vessel anomalies, congenital, Apr. 298-303 bed and bronchiectasis surgery, Feb. 137 Pulse volume: recordings in diabetic foot, Oct. 739-740

Q Quality

of life: after exenteration,

pelvic Dec. 902 R

Radiation diagnostic (see Radiography) induced brachial plexopathy, omental transposition in, Nov. 850-851 injury, gastrointestinal, omental transposition in, Nov. 833 osteonecrosis of clavicle, omental transposition in, Nov. 845 therapeutic (see Radiotherapy) wound, ischemic, closed with myocutaneous flap, May 359 Radiography of empyema, Jan. 13 of lung abscess with dysphagia, Jan. 62-65 of pneumonia, suppurative, Jan. 45 Radiotherapy of breast cancer, recurrence after, Nov. 819 of neuroblastoma, total body, in children, Mar. 195-196 of oral cancer, complication rate, Aug. 598 of rectum carcinoma, adjuvant, Dec. 918-921 of tongue cancer adjuvant, Aug. 618-623 anterior, recurrence and survival after, Aug. 606 failure, salvage attempt after, Aug. 594 recurrence rates after, Aug. 592-593 selection considerations, Aug. 590-591 small, thin, Aug. 597 947

Radiotherapy (cont./ survival after, Aug. 592-593 of Wilms tumor. Mar. 203-204 Reconstruction abdominal wall (see Abdomen, wall, reconstruction) arterial (see Foot, diabetic, arterial reconstruction in) back (see Back. reconstruction) breast (see Breast, reconstruction) chest wall (see Chest wall, reconstruction) genital, flap use frequency in, May 370 head (see Head, reconstruction) knee (see Knee, reconstruction) lip (see Lip, reconstruction) lower extremity (see Extremities, lower, reconstruction) mandible, flaps for, May 361 mediastinum, results with flaps, May 379-380 neck (see Neck, reconstruction) oral, cervical and pectoral flaps for, Aug. 617 orofacial-mandibular, flaps for, May 361 pelvis, omental transposition in, Nov. 834, 835, 836 perineum (see Perineum) pressure sore (see Pressure sore, reconstruction) rectum, in pelvic cancer, Dec. 912-913 soft tissue, in tongue cancer, Aug. 616-618,619 tibia1 vessel, in diabetic foot, Oct. 754-756 vagina (see Vagina, reconstruction) Rectopexy Marlex mesh, June 420 perineal, June 439-440 presacral, June 418-423 with colonic plication, June 423 with sigmoid resection, June 418-423 Rectosigmoid: redundant, in rectal prolapse, June 405 Rectosigmoidectomy: perineal, in rectal prolapse, June 434-437 Rectovaginal septum, Dec. 896 Rectum adenocarcinoma, Dec. 895 carcinoma locally advanced, omental transposition in, Nov. 836-837 pelvic exenteration in (see Pelvis 948

exenteration, in rectum carcinoma) radiotherapy in, adjuvant, Dec. 918-921 intussusception of, June 406 plication, longitudinal, June 430 prolapse, June 402-451 abdominal procedures, June 414-432 anal orifice encirclement in, June 432-434 anal sphincters in, June 405 anatomical considerations, June 404-407 anatomical factors for, predisposing, June 405 author’s experience, June 445-446 in children, June 413 clinical features, June 409-410 colopexy in, June 417-418 continence restoration after surgery of, June 443 cul-de-sac, abnormally deep, June 405 cul-de-sac, obliteration of, June 415 Devadhar operation in, June 430-431 diagnosis, differential, June 411-413 diagnostic characteristics, June 412 Dunphy operation in, June 416-417 etiology, June 403-409 graciloplasty in, June 438-439 Graham operation in, June 416-417 incidence, June 403 incontinence after surgery, problem of. June 442-445 investigation, June 410-411 Ivalon sponge repair of, June 427-429 levator ani in, June 405 levator ani plication in, June 416 Loygue procedure in, June 420 Moschowitz operation in, June 414-415 perineal procedures, June 432-439 perirectal injection of sclerosing agent, June 413 physiologic considerations in, June407-409 puborectalis sling operation in, June431-432

rectal attachments, loss of, June 405 rectopexy in, perineal, June 439 rectosigmoid, redundant, June 405 rectosigmoidectomy in, perineal, June434-437 resection, low anterior, June 429-430 resection, mucosal sleeve, June 437-438 Ripstein operation (see Ripstein operation) surgical procedures, June 414 surgical procedures, principles of, June 415 Teflon sling repair of, June 424 terminology, June 403 transsacral approaches, June 440-441 treatment, June 413-441 treatment, nonoperative, June 413-414 true, vs. mucosal prolapse, June 412 reconstruction in pelvic cancer, Dec. 912-913 surgery, omental transposition in, Nov. 834-836 wall plication with mucosal sleeve resection, June 437 Rectus abdominis myocutaneous flap, May 336 femoris myocutaneous flap, May 338 Reflux: gastroesophageal, and gastrostomy, Sept. 687-688 Renal tumors: in children, Mar. 198-211 Respiratory tract, lower, embryology of, Apr. 252-256 alveolar elements of, Apr. 252-255 bronchial elements in, Apr. 252-255 normal, Apr. 252-256 vascular supply, Apr. 255-256 Rest pain in diabetic foot, Oct. 741-742 criteria for, Oct. 741-742 Revascularization: in diabetic foot, Oct.. 743-759 Rhabdomyosarcoma, in children, Mar. 170-184 anomalies associated with, Mar. 171 bladder, Mar. 174-177 diagnosis, Mar. 172-173

extraorbital, Mar. 181-182 extremity, Mar. 177-180 familial features. Mar. 171 genitourinary tract, Mar. 174-177 head, Mar. 181-182 historical background, Mar. 170-171 management principles, Mar. 173-174 mortality, and influence of site, Mar. 176 neck, Mar. 181-182 orbital, Mar. 182 paratesticular primary sites, Mar. 180-181 pathology, Mar. 171-172 prostate, Mar. 174-177 staging, Mar. 172-173 by clinical group, Mar. 173 tongue, Aug. 637-638 trunk, Mar. 177-180 uterus, Mar. 174-177 vagina, Mar. 174-177 Rhomboideus major muscle flap, May 342 Rib: in open drainage of empyema, Jan. 24 Ripstein operation in rectal prolapse, June 423-427 complications, June 426 recurrence rates after, June 424 Room isolator, July 507 S Sacral

defects: obliteration of, Dec. 917-918 Salivary gland: tumors, minor, under tongue, Aug. 639 Sarcoma, in children Ewing’s, extraosseous, Mar. 231 leiomyosarcoma, Mar. 233 liposarcoma, Mar. 233 neurofibrosarcoma, Mar. 232-233 soft tissue, small-cell, Mar. 232 synovial, Mar. 231-232 Sartorius muscle flap, May 342 Schwannoma: tongue, Aug. 639 Sci-Med environmental system, July 515-517 Scimitar syndrome, Apr. 298-299, 300 Sclerosing agent: perirectal injection of, June 413 Sensory innervated flaps, May 354-355 Sequestration, Apr. 268-274 anomaly, unusual, Apr. 271 949

Sequestration (cont.) extralobar, Apr. 272 intralobar, Apr. 272-274 Serratus anterior muscle flap, May 342 Sex distribution: of malignant teratoma, in children, Mar. 218 Shriners Burn Institute, July 519-521 Sigmoid resection: with presacral rectopexy, June 418-423 Sinus: post-cystectomy, omental transposition in, Nov. 842 Skin blood supply to, and flaps, May 330 graft, split thickness, of omentum, Nov. 827 irritation after gastrostomy, Sept. 694-695 Smoking: and oropharyngeal cancer, Aug. 569 Soft tissue reconstruction in tongue cancer, Aug. 616-618619 sarcoma, small-cell, in children, Mar. 232 Soleus muscle flap, May 343 for tibia, May 344 myocutaneous flap, May 340 Solid tumors, malignant, in children, Mar. 167-242 (See also Children, cancer) Specialized protective environments: isolators, clinical experience with, Julv 521-541 Sphincter(s) ” anal, in rectal prolapse, June 405 oral, muscle and myocutaneous flaps for, May 363 Sphincteroplasty: plication, June 444 Spine coverage: flaps for, muscle and myocutaneous, May 367 Sputum: expectorated, in lung abscess, Jan. 65 Stamm gastrostomy, Sept. 668-671 completed, Sept. 671 Staphylococcal pneumatocele, Jan. 54 Staphylococcus aureus: in lung abscess, Jan. 58 Stasis: gastric, after omental transposition, Nov. 855 Stenosis: iliac artery, angiodilatation, in diabetic, Oct. 749 Sterilization: in empyema after lung resection, Jan. 35-36 Sternomastoid myocutaneous flap, May 334 950

Sternum:

flap for, muscle and myocutaneous, May 365 (see Gastrostomy, stoma)

Stoma Stomach (See also Gastrointestinal) cancer, omentectomy in, Nov. 812 devascularization after omental transposition, Nov. 856 omentum detachment from, Nov. 814-815 perforation, omental transposition in, Nov. 830-831 separation from abdominal wall after gastrostomy, Sept. 689 stasis after omental transposition, Nov. 855 wall injury, posterior, and gastrostomy, Sept. 692 Stromal tumors: in children, Mar. 221-222 Strvker frames: for isolator. Julv 507 Subperiosteal hemorrhage: ‘in ” neuroblastoma, in children, Mar. 187 Supraglottic lesion: neural pathways referring pain to ear, Aug. 577 Surgical intensive care units, July 541-544 -acquired infection, prevention of, July 541-542 BCNUs on, July 544 design of, architectural, July 542-543 isolators for, July 544 laminar airflow rooms, July 544 standard isolation techniques in, July 543-544 Surgical isolator (see Isolators, surgical) Syme amputation, Oct. 772 Sympathectomy: in diabetic foot, Oct. 781-783 Synovial sarcoma: in children, Mar. 231-232 Synovioma: malignant, in children, Mar. 231-232 Systolic pressure digital, Sept. 739 in tibia1 artery, posterior, measurement of. Oct. 737 T Teflon

sling repair: of rectal prolapse, June 424 Temperature: and crosscontamination in wards, July 501

Temporal

vessels: superficial, Nov a47 Temporalis muscle flap, May 341 forces exerted on mandible by, Aug. 630 Tendon flaps that carry, May 352 patellar, defect reconstruction, flap for, May 371 vascularized, compound myocutaneous flap carrying, May 353 Tensor fascia lata myocutaneous flap, May 337-338 Teratoma, malignant, in children, Mar. 216-220 diagnosis, Mar. 217 age at, Mar. 218 pathology, Mar. 216-217 sex distribution. Mar. 218-220 site of origin, Mar. 218 therapy, Mar. 217-220 Testes. tumors. in children. Mar 223-226 classification, Mar. 224 diagnosis, Mar. 225 incidence, Mar. 224 therapy, Mar. 225-226 Thanatonhoric dwarf. Apr. 281 Thiersch procedure, June 432 Notaras variation of, June 434 Thigh flaps for, muscle and myocutaneous, May 370 flaps from, myocutaneous, May 340 Thoracentesis, Jan. 79 amebic empyema responding to, Jan. 75 Thoracic (See also Chest) dystrophy, asphyxiating, Apr. 262 surgery, omental transposition in, Nov. 847449 Thoracoacromial vessels, Aug. 619 Thoracoplasty: in bronchopleural fistula, Jan. 38 Thorax (see Chest) Thrombosis: venous, after omental transposition, Nov. 854 Tibia in osteomyelitis, muscle flap closure, May 357 soleus muscle flap for, May 344 Tibia1 artery, posterior, systolic pressure measurement in, Oct. 737

vessel

reconstruction in diabetic foot, Oct. 754-756 Tobacco smoking: and oropharyngeal cancer, Aug. 569 Toe “blue toe syndrome,” Oct. 751 gangrenous, in diabetic, Oct. 779 treatment, Oct. 768-769 pressures in prediction of healing of amputations in diabetic, Oct. 762-763 Tomography, computed of breast cancer recurrence, Nov. 821 in lung abscess, Jan. 64 of lung cystic adenomatoid malformation, congenital, Apr. 297 of lung herniation, Apr. 251 in neuroblastoma, in children, Mar. 192 of omentum in ovarian cancer, Nov. 811 of Wilms tumor, bilateral, Mar. 200 Tongue base, anatomical relations of, Aug. 575 cancer (see below) carcinoma, verrucous, Aug. 638-639 examination, Aug. 573 hemangioma, Aug. 639 lesions neural pathways referring pain to ear, Aug. 577 odd, Aug. 639 myoblastoma, granular cell, Aug. 639 resection (see Tongue cancer, tongue resection in) rhabdomyosarcoma, in children, 637-638 salivary gland tumors under, minor, Aug. 639 schwannoma, Aug. 639 Tongue cancer, Aug. 565-653 ablation of primary site with adequate margin, Aug. 610-623 anterior pull-through operation for, Aug. 599,600, 601, 602 surgery, recurrence and survival after, Aug. 606 base mandible resection, Aug. 631 pectoralis myocutaneous flap in, Aug. 632 951

Tongue cancer (cont.) treatment, guidelines, Aug. 629 treatment, results, Aug. 624-626 treatment, techniques, Aug. 628-634 biopsy, Aug. 578-579 chemotherapy, Aug. 634-637 diagnosis, Aug. 570-578 etiology, Aug. 568-570 immunotherapy, Aug. 637 large, soft tissue reconstruction in, Aug. 616-618, 619 mandible resection in, Aug. 613-615 with tongue resection, Aug. 612-613 massive, treatment of contralateral lymph nodes for, Aug. 615-616 moderate-sized, more invasive, treatment options, Aug. 604-607 neck dissection for, Aug. 607-610 posterior third, Aug. 623-628 problem of, Aug. 567-578 pull-through procedure, Aug. 611-612 radiotherapy (see Radiotherapy, of tongue cancer) salvage attemnt after irradiation therapy failure, Aug. 594 self-inflicted, Aug. 570 small, thin excision margins, adequate, Aug. 596 excision margins, inadequate, Aug. 595 treatment, Aug. 589-604 staging, Aug. 579-583 surgery, selection considerations, Aug. 590-591 tongue resection in nonstandard, Aug. 613, 614 with resection of margin of mandible, Aug. 612-613 treatment historic background, Aug. 583-588 options, selection of, Aug. 588-589 planning, Aug. 583-588 Toxicity: and lung abscess, Jan. 63 Trachea agenesis, Apr. 256-257 atresia, Apr. 256-257 diverticulum, Apr. 258-259 Tracheal bronchus, Apr. 258-259

952

Transmetatarsal amputation (see Amputation in diabetic, transmetatarsal) pulse volume recordings, Oct. 740 Transplantation (see Marrow, transplantation) Trapezius myocutaneous flap, May 334 Trexler Isolator, July 502-506 diagram of, July 506 Trexler-Vickers Isolator, July 494, 496-499,506 bed, July 510, 511 Trunk: rhabdomyosarcoma, in children, Mar. 177-180 Tube gastrostomy (see Gastrostomy, tube) nasogastric, vs. gastrostomy, Sept. 683-685 Tumors germ cell, in children, Mar. 220-221 extragonadal, Mar. 233 kidney, in children, Mar. 198-211 lung, Apr. 297-298 lung cysts and, in children, Apr. 286 malignant (see Cancer) mediastinal, in neuroblastoma, in children, Mar. 187 recurrence after omental transposition, Nov. 856 salivary gland, minor, under tongue, Aug. 639 solid, malignant, in children, Mar. 167-242 (See also Children, cancer) stromal. in children. Mar. 221-222 testes (see Testes, tumors, in children) Wilms (see Wilms tumor) U Ulcer decubitus, May 367-369 heel. in diabetic. Oct. 773-776 neuropathic, of foot, Oct. 731-732 treatment, Oct. 767-768 pressure (see Pressure sore) Ulm flexible film plastic isolator, July 503 Ultraclean air, July 462-473 in heart surgery, July 473 laminar airflow, July 463-466 study of, major multicenter, July 469-473

Ultrasound prenatal, in congenital cystic adenomatoid malformation of lung, Apr. 295 of Wilms tumor, Mar. 202-203 Ultraviolet light: in nosocomial infection prevention, July 474-479 Ureteroileal open anastomosis: illustration, Dec. 911 Ureterolysis: omental transposition in, Nov. 842 Urinary diversion: in pelvic cancer, Dec. 908-912 Urology: omental transposition in, Nov. 839-843 Uterus: rhabdomyosarcoma, in children. Mar. 1’74-177

v Vagina adenocarcinoma, clear cell, in children, Mar. 234 reconstruction in cancer, Dec. 914-915 with gracilis myocutaneous flap, May 339 rhabdomyosarcoma, in children, Mar. 174-177 Valve cutter: Leather’s intraluminal, act. 755 Valvulotome: Mill’s, Oct. 755 van der Waaij: bed isolator design by, July 518 Vanillylmandelic acid: in neuroblastoma, in children, Mar. 197 Vastus lateralis muscle flap, May 342 medialis myocutaneous flap, May 338-339 Vein bypass, in situ, in diabetic foot, Oct. 753-754 new horizons, Oct. 754 grafts, reversed, in diabetic foot, Oct. 756-759 portal, system, Nov. 799 thrombosis after omental transposition, Nov. 854 Ventilated suits: whole body exhaust, major multicenter study of, July 469-473 Ventral hernia: after gastrostomy, Sept. 689-691

Vesicovaginal fistula (see Omentum, greater, transposition, in vesicovaginal fistula) Vesicovaginorectal fistula: omental transposition in, Nov. 840-841 Vessels in leg, lower third, distal anastomoses to, in diabetic foot, Oct. 758 pulmonary (see pulmonary, vessel) supply for muscle flap, May 324-325, 326 of respiratory tract, lower, Apr. 255-256 temporal, superficial, Nov. 847 thoracoacromial, Aug. 619 tibial, reconstruction in diabetic foot, Oct. 754-756 Vomiting: and gastrostomy, Sept. 703 W Wards:

control of microbial crosscontamination on, July 500-544 Wells procedure, June 427 Wilms tumor, in children, Mar. 198-211 anomalies and, congenital, Mar. 198-199 bilateral, Mar. 209-210 CT of, Mar. 200 chemotherapy, Mar. 203-204 classification, new histologic, from NWTS 2, Mar. 205-206 diagnosis, Mar. 199-200 genetic factors in, Mar. 198-199 histology in prognosis, significance of, Mar. 207 incidence, Mar. 198-199 metastases at diagnosis, Mar. 208 National Wilms Tumor Studies 1, Mar. 204-205 2, Mar. 205 3, Mar. 206-208 results. Mar. 204-208 outcome,‘factors influencing, Mar. 206 radiotherapy of, Mar. 203-204 recurrent, Mar. 208-209 stage IV, Mar. 208 staging. Mar. 200-201 surger$, initial, Mar. 201-203 ultrasound of, Mar. 202-203 Witzel gastrostomy, Sept. 671

953